Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $152,430 - $191,868
-1,495 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $159,023 - $195,366
1,495 New
1,495 $194 Million
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $70,339 - $81,058
-894 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $64,090 - $81,559
894 New
894 $82,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.